Novartis (NVS) News Today $122.37 -0.10 (-0.08%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$123.05 +0.68 (+0.55%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Marshall Financial Group LLC Acquires New Stake in Novartis AG $NVS1 hour ago | marketbeat.comDynamic Advisor Solutions LLC Acquires 3,861 Shares of Novartis AG $NVS5 hours ago | marketbeat.comSivia Capital Partners LLC Boosts Stake in Novartis AG $NVSSeptember 18 at 7:18 AM | marketbeat.comDivergent Planning LLC Takes Position in Novartis AG $NVSSeptember 18 at 5:09 AM | marketbeat.com5,621 Shares in Novartis AG $NVS Bought by Jackson Square Capital LLCSeptember 18 at 5:06 AM | marketbeat.comNovartis AG $NVS Shares Sold by Acadian Asset Management LLCSeptember 17 at 3:19 AM | marketbeat.comNovartis AG $NVS Shares Bought by Baker Ellis Asset Management LLCSeptember 16 at 6:46 AM | marketbeat.comDouglas Lane & Associates LLC Cuts Stake in Novartis AG $NVSSeptember 16 at 5:01 AM | marketbeat.comNovartis AG $NVS Shares Sold by Arvest Investments Inc.September 16 at 4:29 AM | marketbeat.comRhumbline Advisers Raises Stock Position in Novartis AG $NVSSeptember 16 at 3:49 AM | marketbeat.comFocus Partners Wealth Buys 6,849 Shares of Novartis AG $NVSSeptember 16 at 3:07 AM | marketbeat.comMonte Rosa, Novartis Use AI-Powered Engine To Advance Immune Disease TreatmentsSeptember 15, 2025 | benzinga.comNovartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio AcquisitionSeptember 15, 2025 | msn.comNovartis, Monte Rosa strike $5.7 billion drug development dealSeptember 15, 2025 | reuters.com3,124 Shares in Novartis AG $NVS Acquired by Integrity Alliance LLC.September 15, 2025 | marketbeat.comNovartis AG $NVS Stock Holdings Lowered by Bayforest Capital LtdSeptember 15, 2025 | marketbeat.comModern Wealth Management LLC Purchases New Position in Novartis AG $NVSSeptember 15, 2025 | marketbeat.comNovartis (NYSE:NVS) Shares Gap Down - Here's What HappenedSeptember 14, 2025 | marketbeat.comNovartis (NYSE:NVS) Earns Sell Rating from The Goldman Sachs GroupSeptember 14, 2025 | marketbeat.comOsterweis Capital Management Inc. Raises Position in Novartis AG $NVSSeptember 14, 2025 | marketbeat.comNovartis AG $NVS Holdings Raised by Advisors Capital Management LLCSeptember 14, 2025 | marketbeat.comNovartis (NYSE:NVS) Given "Sell" Rating at The Goldman Sachs GroupSeptember 14, 2025 | americanbankingnews.comGeneos Wealth Management Inc. Acquires 3,126 Shares of Novartis AG $NVSSeptember 13, 2025 | marketbeat.comSCS Capital Management LLC Invests $586,000 in Novartis AG $NVSSeptember 13, 2025 | marketbeat.comNovartis AG $NVS Shares Purchased by Great Lakes Advisors LLCSeptember 13, 2025 | marketbeat.comNovartis AG $NVS Shares Sold by Jones Financial Companies LllpSeptember 13, 2025 | marketbeat.comGoldman Sachs Downgrades Novartis AG - Depositary Receipt () (NVS)September 12, 2025 | msn.comNovartis Catches a ‘Sell.' Goldman Sachs Says the Stock Is Overvalued.September 12, 2025 | barrons.comNovartis downgraded to Sell from Neutral at Goldman SachsSeptember 12, 2025 | msn.comAscent Group LLC Grows Position in Novartis AG $NVSSeptember 12, 2025 | marketbeat.comNovartis AG Faces Sell Rating Amid Overvaluation and Looming Generic CompetitionSeptember 12, 2025 | tipranks.comGoldman Sachs Group Inc. Has $408.07 Million Stock Position in Novartis AG $NVSSeptember 11, 2025 | marketbeat.comIntegrated Wealth Concepts LLC Sells 2,940 Shares of Novartis AG $NVSSeptember 11, 2025 | marketbeat.comNewEdge Advisors LLC Has $8.59 Million Position in Novartis AG $NVSSeptember 10, 2025 | marketbeat.comBuyout Of Tourmaline By Novartis Primarily On Pacibekitug IL-6 Novel Mode Of ActionSeptember 9, 2025 | seekingalpha.comWhy Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'September 9, 2025 | msn.comNovartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 BillionSeptember 9, 2025 | investors.comNovartis' Moonshot Cancer Therapy Could Be Future Growth DriverNovartis is betting big on radioligand cancer therapy, but while the long-term growth story looks strong, NVS stock may face a short-term pullback...September 9, 2025 | marketbeat.comNovartis to acquire Tourmaline Bio in $1.4B all-cash dealSeptember 9, 2025 | msn.comThis Biopharma Stock Is Soaring 58%. Novartis Is Acquiring It.September 9, 2025 | barrons.comTourmaline Bio Merges with Novartis for $1.4 BillionSeptember 9, 2025 | tipranks.comPlancorp LLC Has $955,000 Position in Novartis AG $NVSSeptember 9, 2025 | marketbeat.comTourmaline Bio To Be Acquired By Novartis; Was TRML Stock In Your Investment Portfolio? September 9, 2025 | rttnews.comNovartis Agrees to Buy Tourmaline Bio in $1.4 Billion-Dollar DealSeptember 9, 2025 | wsj.comNovartis to acquire Tourmaline Bio in deal valuing it at $1.4 billionSeptember 9, 2025 | reuters.comNovartis price target raised to CHF 105 from CHF 100 at Morgan StanleySeptember 8, 2025 | msn.comParkwood LLC Sells 11,614 Shares of Novartis AG $NVSSeptember 8, 2025 | marketbeat.com11,722 Shares in Novartis AG $NVS Purchased by Alyeska Investment Group L.P.September 8, 2025 | marketbeat.comNovartis FY2027 EPS Forecast Increased by Zacks ResearchSeptember 7, 2025 | marketbeat.comNew Vernon Capital Holdings II LLC Has $154.20 Million Holdings in Novartis AG $NVSSeptember 7, 2025 | marketbeat.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼1.240.68▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼3022▲NVS Articles Average Week Get the Latest News and Ratings for NVS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novartis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AZN News NVO News SNY News GSK News TAK News ARGX News ONC News INSM News BNTX News TEVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
